Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Mar;22(1):e2017.00066.
doi: 10.4293/JSLS.2017.00066.

Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids

Affiliations

Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids

Innie Chen et al. JSLS. 2018 Jan-Mar.

Abstract

Background and objectives: Uterine fibroids are a common indication for laparoscopy. Unsuspected sarcoma can pose a serious risk if morcellation is used in the procedure. We sought to determine the clinical factors associated with uterine sarcoma compared with uterine fibroids.

Methods: We conducted a case-control study of 66 women who had hysterectomy for uterine sarcoma from April 1, 2007, to March 31, 2014. Sixty-six patients who had hysterectomy for fibroids were randomly selected as controls.

Results: Women with sarcoma vs women with fibroids, tended to be older (mean ± SD 62.1 ± 10.1 vs 46.5 ± 6.6; P < .0001), were more likely to be postmenopausal (81.8% vs 9.2%; P < .0001), and were more likely to have a history of another nonuterine malignancy (16.7% vs 4.6%; P = .02). Women with sarcoma were more likely to have masses that were subserosal (69.4% vs 34.8%; P < .0001), rather than intramural (11.1% vs 37.0%; P = .01), and to have a solitary rather than multiple uterine mass (56.3% vs 18.5%; P < .0001). They were also more likely to have a history of documented rapid growth (16.7% vs 4.6%; P = .02).

Conclusion: Despite limitations in sample size related to infrequency of uterine sarcoma, our results suggest some preoperative clinical differences between women who have uterine sarcoma vs uterine fibroids. Further studies on such features may assist us in identifying patients who are at higher risk of having a uterine sarcoma among women with a uterine mass contemplating surgery.

Keywords: Case–control; Fibroid; Laparoscopic morcellation; Leiomyoma; Uterine sarcoma.

PubMed Disclaimer

References

    1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidences of uterine leiomyoma in black and white women: ultrasound evidence. Am K Obstet Gynecol. 2003;188:100. - PubMed
    1. Bernatchez-Laflamme SM, Bujold E, Roberge S, Laberge PY. Development of technicality indices of hysterectomies in Quebec. J Obstet Gynaecol Can. 2013;35:144–148. - PubMed
    1. Gale J, Chen I, Rattray D, Guo Y, Singh SS. Strategic change in MIS hysterectomy rate at a tertiary care centre: a 7-year experience. J Obstet Gynaecol Can. 2014;36:20.
    1. Chen I, Bajzak KI, Guo Y, Singh SS. A national survey of endoscopic practice among gynaecologists in Canada. J Obstet Gynaecol Can. 2012;34:257–263. - PubMed
    1. Pritts EA, Vanness DJ, Berek JS, et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg. 2012;12:165–177. - PMC - PubMed

LinkOut - more resources